7 Best Peptides for Diabetic Neuropathy
Seven peptides come up consistently when people research nerve damage from diabetes: ARA-290 is the most discussed by far, backed by a completed Phase II clinical trial showing small fiber nerve regrowth in human subjects; BPC-157 follows with the largest body of preclinical nerve-repair data; and C-Peptide, MOTS-c, GHK-Cu, Cerebrolysin, and Humanin each address a distinct pathway of hyperglycemic nerve damage. The evidence ranges from human trial data to animal models to community-reported use only, and each entry states that distinction plainly. These compounds are numbered by how prominently they appear in the research and in documented real-world use for diabetic neuropathy, not ranked as a recommendation of one over another. MyPeptidePal turns that field of options into a personalized plan.